Routine screening for BRCA1 gene mutation unnecessary
This article was originally published in Clinica
Widespread screening of women for the BRCA1 breast cancer susceptibility gene is not warranted because the number of cancers linked to the gene is so low, two US studies have suggested. However, women with a strong family history of breast or ovarian cancer should be tested, the researchers said.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.